Moreover, Shim et al. investigated CXCR4 and CXCL12 expression in 283 patients with TNBC by immunohistochemistry, who presented with operable early-stage breast cancer and were treated with surgery and adjuvant chemotherapy [37]. The gene discussed is CXCR4; the disease is breast cancer.